Aurobindo Pharma surges on entering EU market for biosimilars

The Hyderbad-based drug maker is planning to enter the European markets for biosimilar drugs.

Shares of Aurobindo Pharma are currently trading 0.69% higher at Rs. 845 on BSE on reports that the Hyderbad-based drug maker is planning to enter the European markets for biosimilar drugs.

The scrip opened higher at Rs. 842 as against its previous close of Rs. 840.55. It hit a high and a low of Rs. 850 and Rs. 842 respectively. So far, 17,000 shares have changed hands on BSE.